Avalon Acquisition Inc. (Nasdaq: AVAC) was a blank-check company incorporated to pursue a business combination in the healthcare and life sciences sector. The SPAC, sponsored by affiliates of Avalon GloboCare Corp, completed its initial public offering in 2021. On June 21, 2023, the company filed a Form 15-12G with the Securities and Exchange Commission, initiating the termination of its class of registered securities under Section 12(g) of the Exchange Act. The filing indicates the company wound down its operations without consummating a de-SPAC transaction, bringing its lifecycle as a publicly registered special purpose acquisition company to a close. Sign up at SpacDesk for full filing history, sponsor profiles, and real-time SPAC analytics on AVAC and the broader SPAC market.